Ann Taylor
Director/Board Member at TERNS PHARMACEUTICALS, INC.
Net worth: - $ as of 29/04/2024
Profile
Dr. Ann E.
Taylor, MD, is an Independent Director at Terns Pharmaceuticals, Inc. She is on the Board of Directors at Comanche Biopharma Corp., Terns Pharmaceuticals, Inc. and Unlearn.AI, Inc. Dr. Taylor was previously employed as a Head-Clinical Biologics by MedImmune LLC and a Chief Medical Officer by AstraZeneca PLC.
She received her undergraduate degree from the University of California San Diego and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Ann Taylor active positions
| Companies | Position | Start |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director/Board Member | 27/09/2021 |
Unlearn.AI, Inc.
 Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Director/Board Member | 09/03/2021 |
Comanche Biopharma Corp.
 Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | Director/Board Member | 11/06/2023 |
Former positions of Ann Taylor
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 31/07/2021 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 28/02/2019 |
Training of Ann Taylor
| Harvard Medical School | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private companies | 3 |
|---|---|
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Technology Services |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Comanche Biopharma Corp.
Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | Commercial Services |
- Stock Market
- Insiders
- Ann Taylor
